Skip to nav Skip to content
Join IDSA
Login

Find Your Why & Find Your Way to IDWeek

What's New

Update Alert: 2024 IDSA AMR Guidance

The 2024 IDSA AMR Guidance is now live and updates most questions, noting fosfomycin's exclusion for pyelonephritis and cUTI, cautious use of amoxicillin-clavulanic acid for ESBL cystitis, piperacillin-tazobactam's inefficacy for ESBL-E, ceftolozane-tazobactam's new role, updated dosing for ceftazidime-avibactam with aztreonam, and new treatments for resistant bacteria.

IDSA Advocacy Delivers Significant Victory for ID in Proposed Medicare Fee Schedule

The Centers for Medicare and Medicaid Services released its calendar year 2025 Medicare Physician Fee Schedule Proposed Rule July 10, including a new “add-on” code for infectious diseases developed and advocated for by IDSA. 

IDSA Releases New Guidelines for Complicated Intra-Abdominal Infections

The Infectious Diseases Society of America has released new guidelines on complicated intra-abdominal infections in children, adults and pregnant people.

View More

Latest Multimedia

Clinical Management and Prevention of Clade II Mpox: Plus, HPAI Update - Jointly hosted with HIVMA

Avian Flu Update

Lessons in Compensation: Online Learning Seminar on How to Assess Compensation Plans

Science Speaks: ID News

Loading...

View All

New in the Journals

View All

Journals

Clinical Infectious DiseasesExternal Link

Clinical Infectious Diseases (CID), one of the most heavily cited journals in the fields of infectio...

Journal of Infectious DiseasesExternal Link

Founded in 1904, The Journal of Infectious Diseases (JID) is the premier global publication for orig...

Open Forum Infectious DiseasesExternal Link

Open Forum Infectious Diseases (OFID) provides a global forum for the publication of clinical, ...

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.